1169698-53-6 Usage
Description
(R)-1-(6-Chloro-pyridazin-3-yl)-pyrrolidin-3-ol is a specific enantiomer of a compound characterized by a pyrrolidine ring structure with a hydroxyl group and a chloro-pyridazine moiety attached. This chemical compound holds potential pharmaceutical applications due to its unique stereochemistry and structural features, which may contribute to its interaction with neurological receptors or other biological targets.
Uses
Used in Pharmaceutical Development:
(R)-1-(6-Chloro-pyridazin-3-yl)-pyrrolidin-3-ol is used as a key component in the development of drugs targeting neurological receptors or other biological targets. Its unique stereochemistry and structural features make it a potentially valuable asset in the synthesis of new pharmaceutical compounds with desired pharmacological properties.
Used in Medical Research:
In the field of medical research, (R)-1-(6-Chloro-pyridazin-3-yl)-pyrrolidin-3-ol serves as a subject of study to explore its potential therapeutic applications. Further research and testing may reveal its effectiveness in various areas of medicine, including the treatment of neurological disorders or other conditions that could benefit from its interaction with specific biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 1169698-53-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,9,6,9 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1169698-53:
(9*1)+(8*1)+(7*6)+(6*9)+(5*6)+(4*9)+(3*8)+(2*5)+(1*3)=216
216 % 10 = 6
So 1169698-53-6 is a valid CAS Registry Number.
1169698-53-6Relevant articles and documents
FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS
-
Page/Page column 48-49, (2009/08/14)
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4 mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
